A

Altos Labs

Biotech startup advancing cellular rejuvenation therapies

Scientist – Neurodegeneration

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCalifornia, USANo salary listed

About the Job

Requirements

  • A Ph.D. in Neuroscience or a related field and at least one year of postdoctoral or industry research experience focused on neurodegeneration.
  • A robust understanding of neurodegenerative disease biology, including the strengths and limitations of rodent models used to study it.
  • An established publication record in the field and experience presenting findings at conferences or similar scientific venues.
  • Extensive practical experience processing and analyzing rodent and human brain tissue samples.
  • Practical experience with animal surgeries, behavior, and vascular biology, and proficiency in imaging and behavioral analysis techniques.
  • Experience working with central nervous system therapeutic modalities such as AAV-based approaches, antisense oligonucleotides, or small molecules.
  • Strong quantitative and statistical judgment to design appropriately powered studies, analyze complex data, and interpret results objectively without over-extrapolating.
  • Ability to work independently, define problems, select approaches, and drive work to conclusions with minimal oversight, using rigorous critical thinking and revising conclusions when evidence warrants.
  • Ability to work effectively in a fast-moving environment where priorities shift and decisions carry significant consequences while maintaining quality.
  • Ability to collaborate across disciplines and communicate complex technical datasets clearly to broad, mixed audiences.
  • Enthusiasm for defining, implementing, and championing technical and cultural standards, including experimental rigor and reproducibility.

Responsibilities

  • Act as scientific lead for a segment of the neurodegeneration portfolio by shaping research questions, designing experiments, and driving studies to actionable, interpretable conclusions.
  • Design and execute in vivo studies using rodent models of neurodegeneration, selecting models, timepoints, and endpoints suited to biological questions and program stages.
  • Process and analyze rodent and human brain tissue, including dissection, regional sampling, fixation, cryopreservation, sectioning, and molecular, biochemical, and histological characterization.
  • Develop and apply quantitative readouts for pathology and disease biology, including protein aggregation, neuroinflammation, cell loss, and vascular integrity markers.
  • Partner with internal in vivo pharmacology, histology, molecular biology, computational, and program management experts, as well as external collaborators and contract research organizations, to deliver shared timelines.
  • Promote high technical and cultural standards, embedding experimental rigor, blinding, randomization, data provenance, and reproducibility in day-to-day operations.
  • Contribute to program strategy and high-level decisions, including go/no-go recommendations, and flag risks early and candidly.
  • Maintain rigorous, traceable records and structured data capture so findings can be reviewed, reproduced, and built upon.
  • Monitor neurodegeneration literature and apply relevant external developments to internal research programs.

Desired Qualifications

  • Some exposure to analyzing biological datasets and a strong desire to build expertise in transcriptomics, proteomics, or spatial approaches.
  • Basic bioinformatics data-processing or programming skills, such as Python or R, and eagerness to apply them to large-scale data management.
  • Interest in expanding knowledge of human post-mortem or biopsy samples and the challenges of cohort-level data.
  • Motivation to learn advanced imaging techniques, spatial biology, or high-content quantitative histology.

About the Company

Altos Labs

Biotech startup advancing cellular rejuvenation therapies

Altos Labs focuses on cell rejuvenation research to restore cellular health and resilience, with the aim of reversing diseases, injuries, and disabilities by programming cells to resist stressors that cause illness. It advances biotech R&D in cellular rejuvenation, producing treatments that can be commercialized for healthcare providers or patients and likely collaborates with research institutions and pharma partners. Unlike purely diagnostic firms, Altos Labs centers on developing breakthrough cellular therapies and regenerative strategies grounded in research, seeking to improve long-term health outcomes. Its goal is to translate cellular rejuvenation science into practical treatments that extend healthspan and reverse disease processes.

Company size
501-1,000
Company stage
Early VC
Total funding
$3.3B
Headquarters
Redwood City, CA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Altos Labs

See more jobs